• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

SCR7 supplier

Supplementary MaterialsSupplementary Details. and 50?for 10 minutes. Supernatant (free [125I]) and

June 18, 2019 by Katherine Lewis Leave a Comment

Supplementary MaterialsSupplementary Details. and 50?for 10 minutes. Supernatant (free [125I]) and pellet (undamaged [125I]-Abinding to rPrPc, 96-well plates were coated with the indicated rPrPc concentrations in PBS starightaway at 4C on a shaker. Plates were used in 37C for thirty minutes and washed with ice-cold PBS twice. Unspecific binding sites had been obstructed with 3% … [Read more…]

Posted in: Blogging Tagged: Mouse monoclonal to 4E-BP1, SCR7 supplier

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by